FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
FibroGen Announces 1-for-25 Reverse Stock Split
June 12, 2025 4:02 PM EDTSAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGens common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the Companys existing trading symbol FGEN, with the new CUSIP number 31572Q881.
The Reverse Stock Split was previously approved by stockholders at the Companys annual meeting of stockholders held on June 4, 2025 (2025 Annual Meeting), with the final ratio... More
